STUDY - Technical - New Dacian's Medicine
Tumors - Oncology
Translation Draft
In this material you have
at your disposal only a simple list of diseases belonging to
this "group" of diseases (with minimum details necessary for
correct identification/catalogue), as it is present in the
"Table Lists of Diseases" published by accredited public
institutions.
In Romania this list is published by the "National Center for the Organization and Assurance of the Information and Information System in the Field of Health" being taken from the "International and Statistical Classification of Diseases and Related Health Problems"...
In Romania this list is published by the "National Center for the Organization and Assurance of the Information and Information System in the Field of Health" being taken from the "International and Statistical Classification of Diseases and Related Health Problems"...
TUMORS - ONCOLOGY
A. Malignant tumours
declared or presumed to be primary, with specified localizations
except those of lymphoid, hematopoietic and related tissues;
1. Malignant tumors of the
lip, oral cavity and pharynx – excludes the skin of the lip;
1.1. Malignant lip tumor
(upper lip, free edge – upper lip: lip lipstick application
area, NOS, boundary between the oral mucosa and skin; Lip, free,
unspecified edge: the boundary between the oral mucosa and NOS
skin; Upper lip, inner face – upper lip: oral face, frene,
mucosa, oral face; The lip, the internal face, unspecified – the
unspecified lip if it is upper or lower: the oral face, the
frene, the mucosa, the oral face; The commission of the lips;
Injury overcoming the lip; Unspecified lip);
1.2. Malignant tumor of
the base of the tongue (dorsal face of the base of the tongue;
Fixed part of NOS language; The posterior third of the tongue);
1.3. Malignant tumor of
the tongue, other parts and unspecified (dorsal face of the
tongue: two-thirds anterior of the tongue, dorsal surface –
excludes the dorsal surface of the base of the tongue; The jugal
part of the tongue: the tip of the tongue; The ventral face of
the tongue: two-thirds anterior of the tongue, the lower face,
the frene of the tongue; Two-thirds of the language, unspecified
part: middle third of noS, mobile part of NOS language; Lingual
amygdala – excludes NOS amygdala; Injury exceeding the tongue:
malignant tumour of the tongue whose point of origin cannot be
classified in any of the categories presented; Unspecified
language);
1.4. Malignant tumor of
the gum – includes the alveolar mucosa (creature) of the gum and
excludes odontogenic malignant tumors (upper gingia; Lower gum;
Unspecified gum);
1.5. Malignant tumor of
the floor of the mouth (Anterior floor of the mouth: before
premolar-canine junctions; The lateral floor of the mouth;
Injury exceeding the floor of the mouth; Floor of the mouth,
unspecified);
1.6. Malignant tumor of
the palate (Hard part of the palate; The soft part of the palace
– excludes the nasopharyngeal wall of the soft part of the
palace; Lueta; Injury overcoming the palace; Unspecified palace:
Ceiling of the oral cavity);
1.7. Malignant tumor of
the mouth, other parts and unspecified (Mucosa of the cheeks:
oral mucosa NOS, internal face of the cheeks; The oral
vestibule: oral mouthpiece, labia gutiera; Retromolar region;
Injury exceeding the mouth, other parts and unspecified;
Unspecified mouth: accessory salivary gland, unspecified
localization, NOS oral cavity);
1.8. Malignant tumor of
the parotid gland;
1.9. Malignant tumor of
the main salivary glands, other and unspecified – excludes
malignant tumors of the salivary glands accessories NOS,
malignant tumors of the accessory salivary glands specified
which are classified by their anatomical location; parotid gland
(submandibular gland: submaxillary gland; Sublingual gland:
lesion exceeding the main salivary glands: malignant tumor of
the main salivary glands whose point of origin cannot be
classified in any of the categories; Main salivary gland,
unspecified: salivary gland (main) NOS);
1.10. Malignant tumor of
the tonsil – excludes the lingual amygdala, the pharyngeal
amygdala (amygdalian fossa; The pillar of the tonsil; Injury
exceeding the amygdala; Unspecified amygdala – pharyngeal
amygdala, NOS, palatine);
1.11. Malignant tumor of
the oropharynx – excludes the amygdala (the pit (foseta)
gloso-epiglotic; The anterior face of the epiglottis:
epiglottis, free edge, gloso-epiglotic fold(s) – excludes
epiglottis (suprahioidal part) NOS; The lateral wall of the
oropharynx; The posterior wall of the oropharynx; Gillial fenta:
brachial cyst (location of tumor); Injury exceeding the
oropharynx: the junction area of the oropharynx; Unspecified
oropharynx);
1.12. Malignant tumor of
the nasopharyngeal (Upper wall of the nasopharyngeal: the
ceiling of the nasopharyngeal; Posterior wall of the
nasopharynx: adenoid tissue, pharyngeal amygdala; The lateral
wall of the nasopharynx: Rosenmuller fossa, Eustache tube hole,
pharyngeal recess; The anterior wall of the nasopharyngeal: the
ceiling of the naso-pharyngeal, the nasopharyngeal wall of the
palatal wave; the posterior (nasal) edge of the choanes, septum;
Injury exceeding oro-pharynx; Unspecified nazopharyngeal wall:
nos nasopharyngeal wall);
1.13. Malignant tumor of
the piriform sinus (Pyriform Fosa);
1.14. Malignant tumor of
the hypopharyngeal – excludes the pyriform sinus
(Retro-cricoidal zone; The ary-epiglottic fold hypopharyngeal
slope: the ary-epiglotic fold marginal area, NOS – excludes the
ary-epiglotic laryngeal slope; The posterior wall of the
hypopharyngeal; Injury overtaking hypopharyngeal; Unspecified
hypopharyngeal: NOS hypopharyngeal wall);
1.15. Malignant tumor of
the lip, oral cavity and pharynx with other localizations and
poorly defined – excludes the oral cavity NOS (Unspecified
pharynx; Waldeyer Ring; Injury exceeding the lip, oral cavity
and pharynx – malignant tumor of the lip, oral cavity and
pharynx whose point of origin cannot be classified in any of the
previous ones);
2. Primary malignant
tumors localized to the digestive organs;
2.1. Malignant tumor of
the esophagus (cervical esophagus, thoracic esophagus; Abdominal
esophagus; Upper third of the esophagus; Middle third of the
esophagus; Lower third of the esophagus; Injury exceeding the
esophagus; Unspecified esophagus);
2.2. Malignant tumor of
the stomach (Cardia: cardiac orifice, cardioesophageal junction,
gastroesophageal junction, esophagus and stomach; The bottom of
the stomach; The body of the stomach; Pyloric antrul: gastric
antrre; Pilor: the pypilor, the pyloric canal; Small curvature
of the unspecified stomach; Large curvature of the unspecified
stomach; Injury exceeding the stomach; Stomach not specified);
2.3. Malignant tumor of
the small intestine (Duoden, Jejun, Ileon – excludes ileo-cecal
valve; Diverticul Meckel; Injury exceeding the small intestine;
Unspecified thin intestine);
2.4. Malignant tumor of
the colon (Check: ileo-cecal valve; Appendix; Ascending colon;
Liver angle of the colon; Transverse colon; Splenic angle of the
colon; The descending colon; Sigmoid colon: sigmoid (angle) –
excludes the recto-sigmoid junction; Injury exceeding the colon;
Unspecified colon: NOS large intestine);
2.5. Malignant tumor of
the rectal-sigmoid junction (Column with rectum; Recto-sigmoid -
colon);
2.6. Malignant tumor of
the rectum (rectal ampula);
2.7. Malignant tumor of
the anus and anal canal (Unspecified anus – excludes anal: edge,
skin, perianal skin; canal: sphincter; Cloaca; Injury exceeding
the rectum, anus and canal: ano-rectal junction, ano-rectal);
2.8. Malignant tumor of
the liver and intrahepatic bile ducts – excludes NOS bile ducts,
secondary malignant tumor of the liver (Carcinoma of the liver
cell: hepato-cellular carcinoma; hepatoma; Carcinoma of the
intrahepatic bile duct: cholangiocarcinoma; Hepatoblastoma;
Angiosarcoma of the liver: the sarcoma of Kupffer cells; Other
sarcophagi of the liver; Other specified liver carcinomas;
Unspecified liver);
2.9. Malignant tumor of
the gallbladder;
2.10. Malignant tumor of
other and unspecified parts of the bile ducts – excludes
intrahepatic bile ducts (Extrahepatic bile duct: NOS bile duct
or passage, choledoc, cystic canal, hepatic canal; Ampula Vater;
lesion exceeding the bile ducts – malignant tumor of the bile
ducts whose point of origin cannot be classified in any of the
categories stated, malignant tumor involving both intrahepatic
and extrahepatic bile ducts; Unspecified bile ducts);
2.11. Malignant tumor of
the pancreas (the head of the pancreas, the body of the
pancreas; Tail of the pancreas, pancreatic canal; Endocrine
pancreas: Langerhans Islands; other parts of the pancreas: the
neck of the pancreas; Injury exceeding the pancreas; Pancreas
not specified);
2.12. Malignant tumor of
the digestive organs, other or poorly defined – excludes
peritoneum and retroperitone (unspecified part intestinal tract:
NOS intestine; spleen – excludes Hodgkin's disease, non-Hodgkin
lymphoma; Injury exceeding the digestive system – excludes
cardio-esophageal junction; Poorly defined localizations of the
digestive system: NOS tract or food canal, NOS gastrointestinal
tract);
3. Malignant tumors of the
respiratory and intraoracic organs – includes the middle ear and
excludes mesothelioma;
3.1. Malignant tumor of
the nasal cavity and middle ear (nasal passages: cartilage of
the nose, nasal corneas, internal nose, nose septum, nose
vestibule – excludes nose bone, NOS nose, olfactory bulb,
posterior edge of the nasal septum and choanes, nose skin; The
middle ear: Eustache trunk, inner ear, mastoid cells – excludes
the auditory canal (external), ear bone (meat), ear cartilage,
ear skin (external));
3.2. Malignant tumor of
the accessory sinuses (Maxillary sinus: antrul (Highmore)
(maxillary); Ethmoidal sinus; Frontal sinus; Sphenoidal sinus;
Injury overcoming the sinuses of the face; Sinus unspecified
accessory);
3.3. Malignant tumor of
the larynx (Glota: Intrinsic larynx, Vocal chord (true) NOS;
Superglota: The ary-epiglotic laryngeal slope, The Epiglotta
(supra-hioidal portion) NOS, the extrinsic larynx, the false
vocal cord; Posterior (laryngeal) face of the epiglottis,
ventricular bands – excludes the anterior face of the
epiglottis, the ary-epiglottic fold (hypopharyngeal side,
marginal area, NOS), Subglota, Laryngeal cartilage, Lesion
exceeding the larynx, unspecified larynx);
3.4. Malignant tumor of
the trachea (Malignant tumor of the bronchi and lung: bronchial
trunk (Pinten/ carina, lung hil), upper bronchi or lung lobe,
middle lobe of the bronchi or lung, lower bronchi or lung lobe,
lesions exceeding the bronchi or lung, bronchi and lung
unspecified);
3.5. Malignant tumor of
the thymus;
3.6. Malignant tumor of
the heart, mediastinum and pleura – excludes mesothelioma
(Heart: pericardium – excludes large vessels; Previous
mediastinum; Posterior mediastinum; Mediastin part unspecified;
Pleura; Injury surpassing the heart, mediastinum and pleura);
3.7. Malignant tumor of
the respiratory system and intraoracic organs, with other
localizations and poorly defined – excludes intraoracic NOS,
thoracic NOS (Upper Respiratory Pathways Unspecified Part;
Injuries exceeding the respiratory and intraoracic organs:
malignant tumor of the respiratory and intraoracic organs whose
point of origin cannot be classified in any of the previous
categories; Badly defined localizations of the respiratory
system: NOS airways);
4. Malignant tumors of the
bones and articular cartilage – excludes the bone marrow NOS,
synovia:
4.1. Malignant tumor of
the bones and articular cartilage sleds of the limbs (Omoplat
and long bones of the upper limbs; Short bones of the upper
limbs; Long bones of the lower limbs; Short bones of the lower
limbs; Injuries exceeding the bones and joint cartilages of the
limbs; Bones and joint cartilages of unspecified limbs);
4.2. Malignant tumor of
the bones and articular cartilages with other and unspecified
localizations – excludes the bones of the limbs, cartilage: ear,
larynx, limbs, nose (cranial and face bones: Maxillary (upper),
orbital bone – excludes carcinoma of any type except intraososor
or odontogenic of the maxillary sinus, upper jaw, jaw bone
(inferior); Craniofacial bones – bone: ethmoidal, frontal,
occipital, orbital, parietal, sphenoid, temporal; Maxillofacial
bones – Bone: NOS face, malar, nasal, zigomatic; Maxillary
(superior); Basal cornets; The bone of the upper jaw; Vomit; The
mandible – The lower jaw bone – excludes carcinoma of any type
except the intraosos or odontogen of the lower jaw, NOS, upper;
the bone of the upper jaw; Spine – excludes sacrum and coccyx;
Sternum ribs and clavicle; Bones of the pelvis, sacrum and
coccyx; Injuries exceeding the bones and articular cartilage –
malignant tumor of the bones and articular cartilages whose
point of origin cannot be classified in any of the previous
categories); Bones and cartilages not specified;
5. Melanoma and other
malignant tumors of the skin – excludes malignant melanoma of
the skin of the genital organs:
5.1. Malignant melanoma of
the skin – excludes malignant melanoma of the skin of the
genital son (malignant melanoma of the lip – excludes the red
edge of the lip; Malignant melanoma of the eyelid including the
cantus; Malignant melanoma of the ear and external auditory
canal; Malignant melanoma of the face with other and unspecified
localizations; Malignant melanoma of the scalp and neck;
Malignant melanoma of the torso – anal: edge, skin – perianal
skin – breast skin; Malignant melanoma of the upper limbs
including the shoulder; Malignant melanoma of the lower limbs
including the hip; Malignant melanoma overcoming the skin;
Malignant melanoma of the unspecified skin: melanoma (malignant)
NOS);
5.2. Other malignant skin
tumors – includes malignant tumor of the sebaceous glands and
sweat glands and excludes Kaposi sarcoma, malignant melanoma of
the skin, skin of the genitals (Lip skin: basocellular carcinoma
of the lip – excludes malignant lip tumor; The skin of the
eyelids including the cantus – excludes the connective tissue of
the eyelid; The skin of the ear and external auditory conduction
– excludes connective tissue of the ear; Face skin with other
and unspecified localizations; Skin of the scalp and neck; The
skin of the torso – anal: the edge, the skin – the perianal skin
– the skin of the breast – excludes the anus NOS; The skin of
the upper limbs including the shoulder; The skin of the lower
limbs including the hip; Injuries overtaking the skin; Malignant
tumor of the unspecified skin);
6. Malignant tumors of
mesotelial and soft tissues:
6.1. Mesothelioma:
Mesothelioma of the pleura – excludes other malignant tumors of
the pleura; Mesothelioma of the peritoneum: mesenter, mesocolon,
epiploon, peritoneum (parietal) (pelvian) – excludes other
malignant tumors of the peritoneum; Mesothelioma of the
pericardium – excludes other malignant tumors of the
pericardium; Mesothelioma with other localizations; Mesothelioma
not specified);
6.2. Kaposi sarcoma
(Kaposi sarcoma of the skin, soft tissues, palate, lymph nodes,
with other localizations, to multiple and unspecified organs);
6.3. Malignant tumor of
the peripheral nerves and autonomic nervous system – includes
sympathetic and parasympathetic nerves and ganglia (sympathetic
nerves of the head – excludes peripheral nerves of the orbit;
Peripheral nerves of the upper limbs including the shoulder;
Peripheral nerves of the lower limbs including the hip;
Peripheral nerves of the chest; Peripheral nerves of the
abdomen; Peripheral nerves of the pelvis; Peripheral nerves of
the trunk unspecified; Injury beyond peripheral nerves and
autonomic nervous system; Peripheral nerves and autonomic
nervous system unspecified);
6.4. Malignant tumor of
retroperitone and peritoneum – excludes Kaposi sarcoma and
mesothelioma (Retroperitoneum; Unspecified parts of the
peritoneum: mesenter, mesocolon, epiploon, peritoneum: parietal
and pelvic; Peritoneum not specified; Injury exceeding
retroperitone and peritoneum);
6.5. Malignant tumor of
other connective and soft tissues – includes blood vessels,
bursa, cartilage, fascia, fat, ligament except uterine,
lymphatic vessels, muscle, synovial and tendon (teaca) and
excludes articular cartilage, larynx and nose, connective tissue
of the breast; Kaposi sarcoma; mesothelioma; peripheral nerves
of the autonomic nervous system; peritoneum; retroperitone
(conjunctive tissue and soft tissues of the upper limbs
including the shoulder; Connective tissue and soft tissues of
the lower limbs including the hip; Connective tissue and soft
tissues of the chest: armpit, diaphragm, large vessels – exclude
sand, heart, mediastinum and thymus; Connective tissue and soft
tissues of the abdomen: abdominal wall and hypochondrium;
Connective tissue and new tissues of the pelvis: buttock, groin,
peritoneum; Connective tissue and soft tissues of the trunk
Injury exceeding connective tissue and soft tissue: malignant
tumour of connective tissue and soft tissues whose point of
origin cannot be classified in any of the previous categories;
Connective tissue and soft tissues);
7. Malignant breast
tumors:
7.1. Malignant breast
tumor – includes connective breast tissue and excludes breast
skin (Mamelon and areola; The central part of the breast; The
super-internal dial of the breast; The infero-internal dial of
the breast; The super-external dial of the breast; The
infero-external dial of the breast; The axillary part of the
breast; Injury overcoming the breast; Unspecified breast);
8. Malignant tumors of the
female genitalorgans – includes the skin of the female
genitalia:
8.1. Malignant tumor of
the vulva: Large lips – Bartholin gland (larger vestibular),
small lips, clitoris, lesion exceeding the vulva, unspecified
vulva;
8.2. Malignant tumor of
the vagina;
8.3. Malignant tumor of
the cervix: endocol, exocol, lesion exceeding the cervix,
unspecified cervix;
8.4. Malignant tumor of
the uterine body: uterine isthmus – lower uterine segment,
endometrium, myometer, the bottom of the uterus, lesion
exceeding the bottom of the uterus, the body of the uterus
unspecified;
8.5. Malignant tumor of
the uterus unspecified part;
8.6. Malignant tumor of
the ovary;
8.7. Malignant tumor of
other and unspecified female genitalia: Fallopian tube –
oviduct, fallopian tube; broad ligament; round ligament;
parameter – NOS uterine ligament, unspecified uterus appendages,
other genital organs specified in the woman – Wolffian body or
canal, lesion exceeding the genital organs in the woman –
malignant tumor of the female genitalia whose point of origin
cannot be classified in any of the previous categories;
8.8. Malignant tumor of
the placenta (Coriocarcinoma NOS, Corioepitelioma NOS – excludes
chorioadenoma (destructive), hydatiform mola: invasive,
malignant NOS);
9. Malignant tumors of the
male genitalia – includes the skin of the male genitalia:
9.1. Malignant tumor of
the penis: foreskin (a skin cut covering the foreskin), the
penis gland, the penile body (cavernous body), lesion exceeding
the penis, unspecified penis – the skin of the penis NOS;
9.2. Malignant tumor of
the prostate;
9.3. Malignant tumor of
the testicle: cropptorhidic testicle (ectopic testicle, retained
testicle), lowered testicle (scrotal testicle), unspecified
testicle;
9.4. Malignant tumor of
other and unspecified male genitalia: epididymis, spermatic
cord, scrotum (scrotum skin), other genital organs specified in
men (seminal vesicle, vaginal tunic), lesion exceeding male
genitalia – malignant tumor of male genitalia whose point of
origin cannot be classified in any of the previous categories;
genital organ in unspecified men – genitourinary pathways in noS
men;
10. Malignant tumors of
the urinary tract:
10.1. Malignant tumor of
the kidney except the renal basin – excludes chalices and
pelvis;
10.2. Malignant tumor of
the renal basin; pelvic-ureteral junction, renal chalices;
10.3. Malignant tumor of
the ureter – excludes the ureteral orifice of the bladder;
10.4. Malignant tumor of
the bladder: the trigon of the bladder, the bladder vault, the
lateral wall of the bladder, the anterior wall of the bladder,
the posterior wall of the bladder, the bladder (internal
urethral orifice), the ureteral orifice, the uraca, lesion
exceeding the bladder, the unspecified bladder);
10.5. Malignant tumor of
other and unspecified genital organs – excludes noS
genitourinary pathways – female and male (Uretra – excludes the
urethral orifice of the bladder; Urethral glands; Injury
exceeding the urinary organs – malignant tumor of the urinary
organs whose point of origin cannot be classified in any of the
previous categories; Unspecified urinary organ – NOS urinary
system);
11. Malignant tumors of
the eye, brain and other parts of the central nervous system:
11.1. Malignant tumor of
the eye and its appendages – excludes the connective tissue of
the eyelid, eyelid (skin), optic nerve: Conjunctiva; Cornea;
Retina; Coroid, Ciliary Body (eyeball); The tear gland and the
tear duct: the tear sac, the naso-lacrimal canal; Orbit:
connective tissue of the orbit, extra-ocular muscle, peripheral
nerves of the orbit, retro-ocular tissue, retro-bulbar tissue –
excludes the orbital bone; Injury exceeding the eye and its
appendages; The unspecified eye;
11.2. Malignant tumor of
the meninges: Cerebral meninges; Rahidian meninge; Meninge
unspecified;
11.3. Malignant brain
tumor – excludes cranial nerves, retrobulbar tissue: Brain
except lobes and ventricles (calos, supratentorial NOS body),
Frontal lobe, temporal lobe, parietal lobe, occipital lobe,
cerebral ventricle – excludes fourth ventricle, cerebellum,
cerebral trunk (fourth ventricle, infratentorial NOS), Lesion
exceeding the brain, Brain unspecified;
11.4. Malignant tumor of
the spinal cord, cranial nerves and other parts of the central
nervous system – excludes meninges, peripheral nerves and
autonomic nervous system: Spinal cord; Horsetail; The olfactory
nerve (olfactory bubble); Optical nerve; The auditory nerve;
Other cranial nerves and unspecified; Injury exceeding the
central nervous system (malignant tumor of the brain and other
parts of the central nervous system whose point of origin cannot
be classified in any of the previous categories); Unspecified
central nervous system (NOS nervous system);
12. Malignant tumors of
the thyroid and other endocrine glands:
12.1. Malignant tumor of
the thyroid gland;
12.2. Malignant tumor of
the adrenal gland: Cortical adrenal gland, Medular adrenal
gland, unspecified adrenal;
12.3. Malignant tumor of
other endocrine glands and related structures – excludes the
adrenal gland, endocrine pancreas, ovary, testicle, thymus,
thyroid gland: Parathyroid gland, Hypophysis, cranio-pharyngeal
canal, pineal gland (epiphysis), carotid corpuscle, aortic
glomus and other paraganglions, unspecified pluriglandular touch
(if the localizations of pluriglandular touches are known they
should be classified in other categories), unspecified endocrine
gland;
13. Malignant tumors with
poorly defined, secondary and unspecified localizations:
13.1. Malignant tumor with
other localizations and unspecified – excludes malignant tumor
of NOS, female genitourinary pathways, male, lymphoid,
hematopoietic and related tissue, unspecified localizations:
Head, face, neck (cheek and nose NOS), Torace (NOS, intraoracic
ax, NOS thoracic), Abdomen, Pelvis (inghinal NOS, localizations
that exceed pelvic systems such as (sept) recto-vaginal, (sept)
recto-vescal), Upper member, Lower member, Other unspecified
localizations, Lesion exceeding other locations and
13.2. Secondary and
unspecified malignant tumor of the lymph nodes – excludes
malignant tumor of the lymph nodes specified as primary: Head
lymph nodes, face and neck, sublavilal lymph nodes, intraoracic
lymph nodes, intra-abdominal lymph nodes, lymph nodes of the
armpit and upper limb (pectoral lymph nodes), inguinal and lower
limb lymph nodes, intrapelvian lymph nodes, multiple-local lymph
nodes, unspecified lymph nodes;
13.3. Secondary malignant
tumor of the respiratory and digestive organs: Secondary
malignant tumor of the lung; Secondary malignant tumor of the
mediastinum; Secondary tumor of the pleura; Secondary malignant
tumor of the respiratory and digestive organs other than those
specified; Secondary malignant tumor of the small intestine;
Secondary malignant tumor of the large intestine and rectum;
Secondary malignant tumor of retroperitone and peritoneum – noS
malignant ascites; Secondary malignant tumor of the liver;
Secondary malignant tumor of other and unspecified digestive
organs;
13.4. Secondary malignant
tumor with other localizations: Secondary malignant tumor of the
kidney and pelvis; Secondary malignant tumor of the bladder and
other urinary organs and unspecified; Secondary malignant tumor
of the skin; Secondary malignant tumor of the brain and cerebral
meninges; Secondary malignant tumor of other and unspecified
parts of the nervous system; Secondary malignant tumor of the
bone and bone marrow; Secondary malignant tumor of the ovary;
Secondary malignant tumor of the adrenal gland;
13.5. Secondary malignant
tumor with other specified localizations: Secondary malignant
tumor of the breast – excludes the skin of the breast; Secondary
malignant tumor of the genitalorgans; Secondary malignant tumor
with other specified localizations;
13.6. Malignant tumours
with unspecified site: Cancer with unspecified (primary)
(primary) localization; Carcinoma with unspecified (primary)
(primary) localization; Carcinomatosis with unspecified
localization (primary)(secondary); Generalized: cancer with
unspecified (primary) (primary) localization; malignancy with
unspecified (primary) (secondary) localization; multiple cancer
with unspecified (primary) (primary) localization; malignant
cheesexia; unknown primary location.
14. Malignant tumors of
lymphoid, hematopoietic and related tissues (terms are used for
non-Hodgkin lymphomas) – excludes unspecified secondary
malignant tumor of the lymph nodes:
14.1. Hodgkin's disease:
Lymphocytic predominance: Lymphocytic-histocytic predominance;
Nodular sclerosis; Mixed cell; Lymphocytic depletion; Another
form of Hodgkin's disease; Unspecified Hodgkin's disease;
14.2. Non-Hodgkin's
follicular (nodular) lymphoma – includes non-Hodgkin's
follicular (nodular) lymphoma with or without diffuse zones:
small notched follicular cells; Mixture of small notched cells
and large follicular cells; Large follicular cells; Other forms
of non-Hodgkin's follicular lymphoma; Non-Hodgkin's follicular
lymphoma not specified – Non-Hodgkin NOS nodular lymphoma;
14.3. Non-Hodgkin's
Diffuse Lymphoma: Small Cells (Diffuse); Small crested cells
(diffuse); Mixture of large and small cells (diffuse); Large
cells (diffuse) – reticulosarcoma; Immunoblastic (diffuse);
Lymphoblastic (diffuse); Undifferentiated (difuse); Burkitt
tumor; Other forms of diffuse non-Hodgkin lymphoma; Non-Hodgkin
diffuse lymphoma not specified;
14.4. Peripheral and Skin
Z-Cell Lymphomas: Fungoid Mycoses; Reticulosis Seszary; Lymphoma
of the T-zone; Lymphoepiteloid lymphoma – Lennert lymphoma;
Peripheral T-cell lymphoma; Other and unspecified T-cell
lymphoma;
14.5. Other types of
non-Hodgkin lymphoma and unspecified: Lymphosarcoma; Unspecified
B-cell lymphoma; Other specified types of non-Hodgkin lymphoma –
malignant: reticuloendoteliosis, reticulosis – microglioma;
Non-Hodgkin lymphoma of the unspecified type: NOS lymphoma, NOS
malignant lymphoma, Non-Hodgkin NOS lymphoma;
14.6. Malignant
immunoproliferative diseases: Waldenstrom microglobulinemia;
Disease of alpha heavy chains; Gamma heavy chain disease –
Franklin's disease; Immunoproliferative disease of the small
intestine – Mediterranean lymphoma; Other malignant
immunoproliferative diseases; Malignant immunoproliferative
disease; Unspecified malignant immunoproliferative disease – NoS
immunoproliferative disease;
14.7. Multiple myeloma and
malignant tumors with plasmocytes: Multiple myeloma (Kahler
disease, Myelomaosis – excludes solitary myeloma); Plasmocyte
leukemia; Extra-medular plasmocytoma (Malignant tumor with NOS
plasmocyte; Plasmocytoma NOS; Solitary myeloma NOS);
14.8. Lymphoid leukemia
(acute lymphoblastic leukaemia - excludes acute release during
chronic lymphocyte leukemia; Chronic lymphoid leukemia; Acute
lymphoid leukemia; Leukemia with prolymphocytes; Hairy cell
leukemia: Leukemic reticulo-endoteliosis; Adult leukemia with T
lymphocytes; Other lymphoid leukaemias: Leukemia with
lymphosarcoma cells; Unspecified lymphoid leukaemia);
14.9. Myeloid leukaemia –
includes leukaemia: granulocytic, myelogenic (Acute myeloid
leukemia – excludes acute pouting during chronic myeloid
leukaemia; Chronic myeloid leukaemia; Subacute myeloid
leukaemia; Myeloid sarcoma: Crorom, Granulocytic sarcoma; Acute
promyelocitary leukaemia; Acute myelomonocytic leukaemia; Other
myeloid leukaemias; Unspecified myeloid leukaemia);
14.10. Monocytic leukaemia
– includes monocytic leukaemia (acute monocytic leukemia –
excludes acute disputation during chronic monocytic leukaemia;
Chronic monocytic leukemia; Subacute monocytic leukemia; Other
monocytic leukaemias; Unspecified monocytic leukaemia);
14.11. Other unspecified
cell leukaemias – excludes leukemic reticulo-endoteliosis,
plasma cell leukaemia (Acute erythremia and erythroleukemia:
Acute erythremic myelosis, Di Guglielmo disease; Chronic
erythremia: Heilmeyer-Schoner disease; Acute leukaemia with
megacarioblasts – Leukemia with: megacarioblasts (acute),
megakaryocytes (acute); Leukemia with mastocytes; Acute
panmyelosis; Acute myelofibrosis; Other specified leukaemias);
14.12. Leukemia with
unspecified type cells (Acute leukemia with unspecified type
cells: Leukaemia with blastocytes, Leukaemia with suse cells –
excludes acute release during non-specific chronic leukaemia;
Chronic leukemia with unspecified cells; Subacute leukemia with
unspecified type cells; Other leukaemias with unspecified cells;
Unspecified leukaemia);
14.13. Other malignant and
unspecified tumors of lymphoid, hematopoietic and related
tissues (Letterer-Siwe disease – Nelipoid:
reticulo-endoteliosis, reticulosis; Malignant histocytosis:
medullary histiocytositic reticulosis; Malignant tumor with
mastocytes – Maligna: mastocytoma, mastocytosis, Sarcoma with
mastocytes – excludes leukemia with mastocytes and mastocytosis
(cutaneous); True histocytic lymphoma; Other specified malignant
tumors of lymphoid, hematopoietic and related tissue; Malignant
tumor of lymphoid, hematopoietic and related tissue
unspecified);
B. Tumors in situ – includes Bowen's disease, erythroplasia, Queyrat erythroplasia
B. Tumors in situ – includes Bowen's disease, erythroplasia, Queyrat erythroplasia
(Note: Many in situ tumors
are believed to be located inside a continuous morphological
change between dysplasia and invasive cancer. For example, for
cervical intraepithelial neoplasia (CIN) three degrees are
recognized, of which the third (CIN III) includes both severe
dysplasia and carcinoma in situ. This grading system has been
extended to other organs such as the vulva and vagina):
1. In situ carcinoma of the oral cavity, esophagus and stomach – excludes melanoma in situ (lip, oral cavity and pharynx: ary-epiglottic pliul: hypopharyngeal slope, marginal area, NOS; Free edge of the lip – excludes the ary-epiglottic fold, the laryngeal slope, the NOS epiglottis, the suprahioid part, the skin of the lip; Esophagus; Stomach);
1. In situ carcinoma of the oral cavity, esophagus and stomach – excludes melanoma in situ (lip, oral cavity and pharynx: ary-epiglottic pliul: hypopharyngeal slope, marginal area, NOS; Free edge of the lip – excludes the ary-epiglottic fold, the laryngeal slope, the NOS epiglottis, the suprahioid part, the skin of the lip; Esophagus; Stomach);
2. In situ carcinoma of
other digestive organs and unspecified – excludes melanoma in
situ (Colon – excludes the recto-sigmoidjunction junction; Rect;
anus and anal canal – excludes anal: edge, skin, perianal skin;
other parts of the intestine and unspecified – excludes Vater's
ampula; Liver, vesicle and bile ducts – Vater's ampula; Other
specified digestive organs – Pancreas; Unspecified digestive
organ);
3. In situ carcinoma of
the middle ear and respiratory system – excludes melanoma in
situ (larynx; The ary-epiglottic fold of the laryngeal slope,
Epiglotta (suprahyid part) – excludes the ary-epiglottic fold:
the hypopharyngeal slope, the marginal area, NOS; Trachea;
Bronchii and lung; Other parts of the respiratory system:
Accessory sinuses, Middle ear; Nasal cavities – excludes the ear
(external) (skin), nose: NOS, skin; Unspecified respiratory
system);
4. Melanoma in situ
(Melanoma in situ of the lip; Melanoma in situ of the eyelid
including the cant; Melanoma in situ of the ear and external
auditory conduction; Melanoma in situ of other parts of the face
and unspecified; Melanoma in situ of the scalp and neck;
Melanoma in situ of the trunk – anal: edge, skin; breast (skin)
(soft tissue); Perianal skin; Melanoma in situ of the upper limb
including the shoulder; Melanoma in situ of the lower limb
including the hip; Melanoma in situ with other localizations;
Melanoma in situ unspecified);
5. Carcinoma in situ of
the skin – excludes queyrat erytroplasia (penis) NOS and
melanoma in situ (Lip skin – excludes the free edge of the lip;
Skin of the eyelid including the cant; Skin of the ear and
external auditory conduction; Skin of other parts of the face
and unspecified; Skin of the trunk – anal: edge, skin; perianal
skin; breast skin – excludes NOS anus and genital skin; The skin
of the upper limb including the shoulder; The skin of the lower
limb including the hip; Skin of other localizations; Unspecified
skin);
6. Carcinoma in situ of
the breast – excludes carcinoma in situ of the skin of the
breast and melanoma in situ of the breast (skin) (Lobular
carcinoma in situ of the breast; Intracanalic carcinoma in situ
of the breast; Another carcinoma in situ of the breast;
Carcinoma in situ of the unspecified breast);
7. In situ carcinoma of
the cervix – includes intraepithelial cervical neoplasia (CIN
III) with or without mention of severe dysplasia and excludes in
situ melanoma of the cervix and severe cervical dysplasia
(Endocol; Exocol; other parts of the cervix; Unspecified
cervix);
8. In situ carcinoma of
other genital organs and unspecified – excludes melanoma in situ
(Endometer; Vulva: Vulvar intraepithelial neoplasia (VIN) with
or without mention of severe dysplasia – excludes severe
dysplasia of the NOS vulva; Vagina: vaginal intraepithelial
neoplasia (VAIN III) with or without mention of severe dysplasia
– excludes severe dysplasia of the noS vagina; Other female
genitalia and unspecified; Penis: queyrat NOS erythroplasia;
Prostate; other male genitalia and unspecified);
9. Carcinoma in situ with
other unspecified localizations – excludes melanoma in situ
(Urinary bladder; Other urine organs and unspecified; Eye –
excludes the skin of the eyelid; Thyroid and other endocrine
glands – excludes the endocrine pancreas, ovary and testicle;
Carcinoma in situ with other specified localizations; Carcinoma
in situ unspecified);
C. Benign tumors:
1. Benign tumor of the
mouth and pharynx (Lip: Buza (frene) (internal face) (mucosa)
(free edge) – excludes lip skin;Tongue: Lingual amygdala; The
floor of the mouth; Other locations of the mouth and
unspecified: NoS accessory salivary gland – excludes benign
odontogenic tumors, lip mucosa, rhinopharyngeal wall of the soft
palate; The amygdala (false) (palatin) – excludes the lingual
amygdala, the tonsil (amygdalian): fossa, pillars; Other parts
of the oropharynx: epiglottis anterior slope, amygdalian
(amygdalian), fossa, pillars, Valeculum – excludes the
epiglottis NOS, the suprahyoid portion; Nazo-pharynx: pharyngeal
amygdala, posterior edge of the septum and choans;
Hypopharyngeal; Unspecified pharynx);
2. Benign tumor of the
main salivary glands – excludes benign tumors of the accessory
salivary glands, malignant tumors of the accessory salivary
glands specified that are classified by their anatomical
location (parotid gland; other main salivary glands – gland:
sublingual, submandibular; Unspecified main salivary gland);
3. Benign tumor of the
colon, rectum, anus and anal canal – excludes polyp, colon
(non-neoplastic) (Cec – ileo-cecal valve; Appendix; Ascending
colon; Transverse colon: hepatic flexure, splenic flexure;
Descending colon; Colon sigmoid; Unspecified colon: adenomatosis
of the colon, noS large intestine, polyposis (hereditary) of the
colon; Recto-sigmoid junction; Rect; Anus and anal canal –
excludes anal: edge, skin, perianal skin);
4. Benign tumor of other
parts of the digestive system and poorly defined (Esophagus;
Stomach – excludes polyp, stomach (hyperplastic) NOS; Duoden –
excludes polyp, duodenum (hyperplastic) NOS; Other parts of the
small and unspecified intestine; Liver: intrahepatic bile ducts;
Extrahepatic bile ducts; Pancreas - excludes the endocrine
pancreas; Endocrine pancreas: tumor of the cellular islands,
Langerhans islands; Poorly defined localizations of the
digestive system: NOS digestive system, NOS intestine, spleen);
5. Benign tumor of the
middle ear and respiratory system (Middle ear, nasal fossa and
facial sinus: cartilage of the nose – excludes the auditory
canal (external), ear bone, nose, ear cartilage, ear (external)
(skin), nose: NOS, skin, olfactory bulb, polyp: sinus,
accessory, ear (medium), nose (cavity), posterior edge of the
septum and choans; Larynx: epiglottis (suprahioid portion) –
excludes the epiglottis of the anterior slope, the polyp of the
vocal cord and larynx; Trachea; Bronchii and lung; Unspecified
respiratory system);
6. Benign tumor of other
intraoracic and unspecified organs – excludes mesotelial tissue
(Timus; Heart – excludes large vessels; Mediastin; Other
specified intraoracic organs; Unspecified intraoracic organs);
7. Benign tumor of the
bone and articular cartilage – excludes connective tissue of the
ear, eyelid, larynx, nose, synovia (Omoplat and long bones of
the upper limb; Short bones of the upper limb; Long bones of the
lower limb; Short bones of the lower limb; Bones of the skull
and face – excludes the bone of the mandible; craniofacial bones
– bone: ethmoid, frontal, occipital, orbital, parietal,
sphenoid, temporal; Maxillofacial bones – bone: NOS face, malar,
nasal, zigomatic, jaw (upper), turbinal, upper jaw bone, vomit;
Mandibular bone; The spine – excludes the sacrum and coccyx;
Ribs, sternum and clavicle; Pelvic bones, sacrum, coccyx; Bone,
unspecified articular cartilage);
8. Benign lipomatous tumor
(benign lipomatous tumor of the skin and subcutaneous tissue of
the head, face and neck; Benign lipomatous tumor of the skin and
subcutaneous tissue of the trunk; Benign lipomatous tumor of the
skin and subcutaneous tissue of the limbs; Benign lipomatous
tumor of the skin and subcutaneous tissue with other and
unspecified localizations; Benign lipomatous tumor of
intraoracic organs; Benign lipomatous tumor of the
intra-abdominal organs – excludes peritoneum and retroperitone;
Benign lipomatous tumor of the spermatic cord; Benign lipomatous
tumor with other localizations: peritoneum, retroperitoneum;
Unspecified benign lipomatous tumor: noS lipoma);
9. Hemangioma and
lymphangioma – excludes blue or pigmentary nevus (Hemangioma:
angioma NOS; Lymphangioma with any localization);
10. Benign tumor of the
mesothelial tissue (Mesothelial tissue of the pleura;
Mesothelial tissue of the peritoneum; Mesothelial tissue with
other localizations; Unspecified mesothelial tissue: benign
mesothelioma NOS);
11. Benign tumor of the
soft tissues of the retroperitone and peritoneum – excludes
benign lipomatous tumor of the peritoneum and retroperitone and
mesothelial tissue (Retroperitoneum; Peritoneum);
12. Other benign tumors of
connective tissue and other soft tissues – include blood vessel,
bursa, cartilage, fascia, fat, ligament except uterine,
lymphatic canal, muscle, synovia, tendon (tea) and excludes
articular cartilage, larynx, nose as well as connective breast
tissue, hemangioma, lipomatous tumor, lymphangioma, peripheral
nerves and autonomic nervous system, peritoneum, retroperitone,
uterine: leiomyoma, any ligament, vascular tissue (Conjunctive
tissue and other soft tissues of the head, face and neck:
connective tissue of the ear, eyelid – excludes connective
tissue of the orbit; Connective tissue and other soft tissues of
the upper limb including the shoulder; Connective tissue and
other soft tissues of the lower limb including connective
tissue; Connective tissue and other soft tissues of the hip :
armpit, diaphragm, large vessels – excludes the heart,
mediastinum, thymus; Connective tissue and other soft tissues of
the abdomen; Connective tissue and other soft tissues of the
pelvis – exclude sin: leiomyoma, any ligament; Connective tissue
and other soft tissues of the trunk not specified – noS back;
Connective tissue and other unspecified soft tissues);
13. Nev melanocyte –
includes nev: blue, hairy, NOS, pigmented (Nev melanocyte of the
lip; Nev melanocyte of the eyelid including cantus; Nev
melanocyte of the ear and external auditory conduction; Nev
melanocyte of other parts of the face and unspecified; Nev
melanocyte of the scalp and neck; Nev melanocyte of the trunk –
anal: edge, skin, perianal skin, breast skin; Nev melanocyte of
the upper limb including the shoulder; Melanocyte nev of the
lower limb including the hip; Nev melanocyte unspecified);
14. Other benign skin
tumors – includes benign tumor of the hair follicles, sebaceous
glands, sweat glands and excludes benign lipomatous tumors,
melanocytes (skin of the lip – excludes the free edge of the
lip; Skin of the eyelid including cantus; The skin of the ear
and external auditory conduction; Skin of other parts of the
face and unspecified; Skin of the scalp and neck; The skin of
the trunk – anal: the edge, the skin, the perianal skin, the
skin of the breast – excludes the anus NOS, the skin of the
genitals; The skin of the upper limb including the shoulder;
Lower limb skin including hip, unspecified skin);
15. Benign breast tumor
(breast: connective tissue, soft parts) – excludes benign breast
dysplasia, breast skin;
16. Leiomyoma of the
uterus – includes benign tumors of the uterus and fibromyoma of
the uterus (Submucous leiomyoma of the uterus; Intramural
leiomyoma of the uterus; Subseros leiomyoma of the uterus;
Leiomyoma of the uterus unspecified);
17. Other benign tumors of
the uterus (uterine neck; Uterine body; Other parts of the
uterus; Uter unspecified);
18. Benign tumor of the
ovary;
19. Benign tumor of other
female and unspecified genital organs – includes the polyp
adenomatos and the skin of the female genitalorgans (Vulva;
Vagina; Fallopian tubes and ligaments: Fallopian tube, uterine
ligament (wide) (round); Other female genitalia specified;
Genital organ in unspecified woman);
20. Benign tumor of the
genital organs in men – includes the skin of the genitals in the
man (Penis; Prostate – excludes hyperplasia of the prostate
(adenomatous), prostate/ prostate: adenoma, enlargement,
hypertrophy; Testicle; Epididym; Scrotum: the skin of the
scrotum; Other male genitalorgans: seminal vesicle, spermatic
cord, vaginal tunic; Genital organ of the unspecified man);
21. Benign tumor of the
urinary organs (Rinichi – excludes renal: chalice, pelvis
(pelvic kidney); Renal pelvis; Ureter – excludes the ureteral
orifice of the bladder; Urinary bladder – bladder orifice:
ureteral, urethral; The urethra – excludes the urethral orifice
of the bladder; other urinary organs – the paraurethral glands;
Unspecified urinary organs – NOS urinary system);
22. Benign tumor of the
eye and its appendages – excludes the connective tissue of the
eyelid, the optic nerve, the skin of the eyelid (Conjunctiva;
Cornea; Retina; Coroida; Ciliar bodies: eyeball; Tear glands and
tear duct: the naso-lacrimal canal; Unspecified orbit:
connective tissue of the orbit, extra-ocular muscle, peripheral
nerves of the orbit, retro-ocular tissue, retrobulbar tissue –
excludes orbital bone; Unspecified eye);
23. Benign tumor of the
meninges (cerebral meninges, spinal meninges; Unspecified
meninges: meningiom NOS);
24. Benign tumor of the
brain and other parts of the central nervous system – excludes
angioma, meninges, peripheral nerves and autonomic nervous
system, retro-ocular tissue (supratentorial brain: cerebral
ventricle, cerebral hemispheres – ,lobe: frontal, occipital,
parietal, temporal – excludes the fourth ventricle;
Infratentorial brain: brain stem, cerebellum, fourth ventricle;
Unspecified brain; Cranial nerves: olfactory bulb; Spinal cord;
Other specified parts of the central nervous system; Unspecified
central nervous system: nervous system (central) NOS);
25. Benign tumor of the
thyroid gland;
26. Benign tumor of other
endocrine and unspecified glands – excludes the endocrine
pancreas, testicle, ovary (Adrenal; Parathyroid; Hypophysis;
Cranio-pharyngeal canal; Epiphysis; Carotid corpuscle; Aortic
glomus and other paraganglions; Other specified endocrine
glands; Multi-glandular touches; Unspecified endocrine glands);
27. Benign tumor with
other localizations and unspecified (lymph nodes; Peripheral
nerves and autonomic nervous system – excludes peripheral nerves
of the orbit; Other specified locations: NOS nose; Benign tumor
with unspecified localization);
D. Tumors with
unpredictable evolution or unknown behavior (this includes
tumors with unpredictable evolution and unknown behavior, i.e.
there is doubt that the tumor is malignant or benign):
1. Tumor with unpredictable evolution or unknown behavior of the oral cavity and digestive organs (lip, oral cavity and pharynx: ary-epiglotic fold hypopharyngeal slope, marginal area, NOS, main salivary glands and accessories, free edge of the lip – excludes the ary-epiglotic fold of the laryngeal slope, the epiglottis NOS and the suprahioid portion, the skin of the lip; Stomach; Thin intestine; Appendix; Colon; Rect: recto-sigmoid junction; Liver and bile ducts: Vater ampula; Other digestive organs – anal: canal, sphincter, Anus NOS, Intestin NOS, Esophagus – excludes anal: edge, skin, perianal skin; Unspecified digestive system);
1. Tumor with unpredictable evolution or unknown behavior of the oral cavity and digestive organs (lip, oral cavity and pharynx: ary-epiglotic fold hypopharyngeal slope, marginal area, NOS, main salivary glands and accessories, free edge of the lip – excludes the ary-epiglotic fold of the laryngeal slope, the epiglottis NOS and the suprahioid portion, the skin of the lip; Stomach; Thin intestine; Appendix; Colon; Rect: recto-sigmoid junction; Liver and bile ducts: Vater ampula; Other digestive organs – anal: canal, sphincter, Anus NOS, Intestin NOS, Esophagus – excludes anal: edge, skin, perianal skin; Unspecified digestive system);
2. Tumor with
unpredictable evolution or unknown behavior of the middle ear
and respiratory and intraoracic organs – excludes the heart
(Larynx: the ary-epiglottic fold of the hypopharyngeal slope,
the marginal area and NOS; Trachea, bronchi and lung; Pleura;
Mediastin; Timus; Other respiratory organs: accessory sinuses,
cartilage of the nose, middle ear, nasal cavities – excludes the
ear (external) (skin), nose/ nose, NOS, skin; Unspecified
respiratory organ);
3. Unpredictability of
tumour or unknown behaviour of the genitalorgans in women (Uter;
Ovar; Placenta: destructive chorio-adenom, invasive or malignant
hydatiform mola – excludes NOS hydatiform mola; Other female
genitalia not specified);
4. Tumor with
unpredictable evolution or unknown behavior of the genital
organs in the man (Prostate; Testicle; Other genitalia in men:
the skin of the genitals in men; Unspecified male genitalia);
5. Tumor with
unpredictable evolution or unknown behavior of the urinary
organs (Rinichi – excludes the renal pelvis; Renal pelvis;
Ureter; Uretra; Urinary bladder; Other urinary organs;
Unspecified urinary organs);
6. Tumor with
unpredictable evolution or unknown behavior of the meninges
(cerebral meninges; Rahidian meninge; Meninge unspecified);
7. Tumor with
unpredictable evolution or unknown behavior of the brain and
central nervous system – excludes peripheral nerves and
autonomic nervous system (supratentorial brain: cerebral
ventricle, cerebral hemispheres – lobe: frontal, occipital,
parietal, temporal – excludes the fourth ventricle;
Infratentorial brain: brain stem, cerebellum, fourth ventricle;
Unspecified brain; Cranial nerves; Spinal cord; Other parts of
the central nervous system; Unspecified central nervous system:
nervous system (central) NOS);
8. Tumor with
unpredictable evolution or unknown behavior of the endocrine
glands – excludes the endocrine pancreas, ovary, testicle,
thymus (Tyroid; Adrenal; Parathyroid; Hypophysis;
Cranio-pharyngeal canal; Epiphysis; Carotid corpuscle; Aortic
glomus and other paraganglions; Pluriglandular touch: multiple
endocrine adenomatosis; Unspecified endocrine glands);
9. Essential policitemia
(Essential policitemia is increasingly considered to be of
malignant morphology);
10. Myelodysplastic
syndromes (dysplastic syndromes are increasingly considered to
have malignant behaviour) (Refractory anemia without
sideroblasts thus declared; Refractory anemia with sideroblasts;
Refractory anemia with excess blasphemy; Refractory anemia with
excess of blasphemy in transformation; Unspecified refractory
anaemia; Other myelodysplastic syndromes; Unspecified
myelodysplastic syndrome: NOS myelodysplasia, NOS preleukemia
(syndrome);
11. Other tumors with
unpredictable evolution or unknown lymphoid, hematopoietic and
related behaviour – myeloproliferative tumors are considered
lately as having a malignant behavior (Tumors with histocytes
and mastocytes with unpredictable evolution or unknown behavior:
nos mastocyte tumor, NOS mastocytoma – excludes mastocytosis
(cutaneous); Chronic myeloproliferative disease: myelofibrosis
(with myeloid metaplasia), unspecified myeloproliferative
disease, myelosclerosis (megacariocyte) with myeloid
metaplasia); Monoclonal gammapathy; Essential thrombocytemia
(hemorrhagic): idiopathic haemorrhagic thrombocytopenia; Other
specified tumors with unpredictable evolution or unknown
behavior of lymphoid, hematopoietic and related tissues; Tumor
with unpredictable evolution or unknown behavior of lymphoid,
hematopoietic and related tissues unspecified:
lymphoproliferative disease NOS;
12. Unpredictability tumor
or unknown behavior with other and unspecified localizations –
excludes neurofibromatosis (non-malignant) (Bone and articular
cartilage – excludes cartilage: ear, larynx, nose, connective
tissue of the eyelid, synovial; Connective tissue and other soft
tissue – connective tissue of: ear, eyelid – excludes cartilage
of the joint, larynx, nose, connective tissue of the breast;
Peripheral nerves and autonomic nervous system – excludes
peripheral nerves of the orbit; Retroperitoneum; Peritoneum;
Skin – anal: edge, skin, perianal skin, breast skin – excludes
NOS anus, genital skin, free edge of the lip; Breast: connective
tissue of the breast, cystosarcoma phillodes – excludes the skin
of the breast; Other specified localizations: eye, heart,
peripheral nerves of the orbit – excludeconnective tissue,
eyelid skin; Unspecified unpredictable and unknown tumor: NOS
tumor proliferation, NOS neoplasm, NOS neoformation, NOS tumor);
Note:
1. Localizations of
primary, poorly defined, secondary and unspecified malignant
neoplasms – This includes malignant tumors for which there is no
clear indication of the original localization of cancer or
cancer is said to be disseminated, diffused or spread without
mentioning the primary localization; Primary localization is
considered to be unknown in both cases.
2. Functional activity –
All tumors are classified regardless of whether they are
functionally active or not.
3. Morphology – There are
a number of major morphological (histological) groups of
malignant tumours: carcinomas including squamous carcinomas
(cells) and adenocarcinomas, sarcomas, other soft tissue tumors
including mesotheliomas, Hodgkin's lymphomas, non-Hodgkin's
lymphomas, leukaemias, other specified types and with specific
localizations and unspecified cancers; Cancer is a generic term
and can be used for any of the above groups, although it is
rarely applied to malignant tumors of lymphatic, hematopoietic
and related tissue; Often, the term carcinoma is used
incorrectly as a synonym for cancer; Tumors are classified
predominantly by localization within large behavioral groups;
Dorin, Merticaru